Viewing Study NCT05501769


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-01-04 @ 2:15 AM
Study NCT ID: NCT05501769
Status: COMPLETED
Last Update Posted: 2025-09-26
First Post: 2022-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
Sponsor: Arvinas Estrogen Receptor, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module